Authors: Suzanne Elvidge , Dr. Oded Ben-Joseph (contributing author)
Navigating uncharted waters, biotech investors, executives and entrepreneurs are finding unique challenges (and opportunities) in a COVID-19 world. Contributing author, Outcome Capital’s Dr. Oded Ben-Joseph, Managing Director and Co-Founder of the Life Sciences Practice.
BOSTON, MA & RESTON, Va.–(BUSINESS WIRE)–Outcome Capital (www.outcomecapital.com) today announced that Steven Wardell and Karl Hess have joined the firm as Senior Advisors for its rapidly growing life science and healthcare practice, bolstering the firm’s expertise in the digital health segment. As business leaders with extensive hands-on operating and entrepreneurial expertise, Messrs. Hess and Wardell […]Read More
RESTON, Va.–(BUSINESS WIRE)–Outcome Capital, an advisory and investment banking firm that serves middle market growth companies in IT services, software, managed services, ADGS, healthcare and life sciences, is pleased to announce that Evergreen Systems, Inc. (the “Company”) has been acquired by Sunstone Partners, a California-based private equity firm. Outcome Capital provided exclusive advisory services to […]Read More